%D8%B3%D9%8A%D8%AA%D8%A7%D8%BA%D9%84%D8%A8%D8%AA%D9%8A%D9%86%E0%A6%B8%E0%A6%BF%E0%A6%9F%E0%A6%BE%E0%A6%97%E0%A7%8D%E0%A6%B2%E0%A6%BF%E0%A6%AA%E0%A6%9F%E0%A6%BF%E0%A6%A8SitagliptinSitagliptin%CE%A3%CE%B9%CF%84%CE%B1%CE%B3%CE%BB%CE%B9%CF%80%CF%84%CE%AF%CE%BD%CE%B7SitagliptinSitagliptinaSitagliptiiniSitagliptine%D7%A1%D7%99%D7%98%D7%90%D7%92%D7%9C%D7%99%D7%A4%D7%98%D7%99%D7%9FSitagliptin%E3%82%B7%E3%82%BF%E3%82%B0%E3%83%AA%E3%83%97%E3%83%81%E3%83%B3%D0%A1%D0%B8%D1%82%D0%B0%D0%B3%D0%BB%D0%B8%D0%BF%D1%82%D0%B8%D0%BDSitagliptine%D0%A1%D0%B8%D1%82%D0%B0%D0%B3%D0%BB%D0%B8%D0%BF%D1%82%D0%B8%D0%BDSitagliptinSitagliptinSitagliptinQ419832%E8%A5%BF%E6%A0%BC%E5%88%97%E6%B1%80
about
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis.Effects of sitagliptin beyond glycemic control: focus on quality of life.A review of sitagliptin with special emphasis on its use in moderate to severe renal impairment.Comparative effects of sitagliptin and metformin in patients with type 2 diabetes mellitus: a meta-analysis.Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver disease.Sitagliptin improves beta-cell function in patients with acute coronary syndromes and newly diagnosed glucose abnormalities--the BEGAMI study.Protective effects of sitagliptin on myocardial injury and cardiac function in an ischemia/reperfusion rat model.Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic ratsEffect of sitagliptin and glimepiride on C-reactive protein (CRP) in overweight Type-2 diabetic patientsSitagliptin protects against hypoxia/reoxygenation (H/R)-induced cardiac microvascular endothelial cell injuryEfficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K StudyProtective role of sitagliptin against oxidative stress in a kainic acid-induced status epilepticus in rats models via Nrf2/HO-1 pathwayPhasic change and apoptosis regulation of JAK2/STAT3 pathway in a type 2 diabetic rat modelControlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus (2006-08-31)
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Sitagliptiini
@fi
Sitagliptin
@de
Sitagliptin
@it
Sitagliptin
@sh
Sitagliptin
@sr
Sitagliptin
@vi
Sitagliptina
@es
Sitagliptine
@nl
sitagliptin
@cy
sitagliptin
@en
type
label
Sitagliptiini
@fi
Sitagliptin
@de
Sitagliptin
@it
Sitagliptin
@sh
Sitagliptin
@sr
Sitagliptin
@vi
Sitagliptina
@es
Sitagliptine
@nl
sitagliptin
@cy
sitagliptin
@en
altLabel
(2R)-4-OXO-4-[3-(trifluorometh ...... -trifluorophenyl)butan-2-amine
@en
486460-32-6
@fr
C16H15F6N5O
@fr
Januvia
@de
Januvia
@el
Januvia
@nl
Januvia®
@cy
Januvia®
@en
MK-0431
@cy
MK-0431
@en
prefLabel
Sitagliptiini
@fi
Sitagliptin
@de
Sitagliptin
@it
Sitagliptin
@sh
Sitagliptin
@sr
Sitagliptin
@vi
Sitagliptina
@es
Sitagliptine
@nl
sitagliptin
@cy
sitagliptin
@en